Genmab (NASDAQ: GMAB) has appointed Anthony Mancini to serve as executive vice president and chief operating officer. Mancini is joining Copenhagen, Denmark-based Genmab from Bristol Myers Squibb (NYSE: BMY), where he is senior vice president and head of US innovative medicines. When he starts at Genmab on March 23, he will be based in New Jersey. Genmab has a portfolio and pipeline of antibody therapies for cancer.
UNDERWRITERS AND PARTNERS
